AOTI (AOTI) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
30 Sep, 2026Executive summary
Achieved robust underlying revenue growth of 18.8% year-over-year to $31.9m in H1 2026, driven by strong VA and Medicaid segments, excluding Arizona Medicaid.
EBITDA increased 16.6% to $3.6m, with margin improving to 10.1% from 9.6% in H1 2025.
Net profit rose 278% to $0.94m, reflecting operational efficiencies and improved working capital.
Positive operating cash flow of $0.9m, reversing a $4.7m outflow in H1 2025.
Positioned for transformational growth with impending CMS Medicare coverage and expanded US market access.
Financial highlights
Total revenues grew 10.8% to $35.3m; underlying revenue growth (ex-Arizona Medicaid) reached 18.8%.
Gross profit margin improved to 88.8% (H1 25: 87.7%).
EBITDA increased to $3.6m, with margin at 10.1%.
Net debt at $6.3m as of 30 June 2026, down from $6.5m at year-end 2025; cash at period end was $13.8m.
Operating expenses increased due to higher staff bonuses, severance, bad debt, and professional fees.
Outlook and guidance
2026 expected to be transformative with final CMS LCD and Medicare coverage anticipated by July 2027.
Full-year 2026 EBITDA expected in line with consensus at $6.8m; confident in net debt and cash flow outlook.
Underlying mid-teens revenue growth (excluding Arizona Medicaid) anticipated, with low single-digit reported growth.
Latest events from AOTI
- 10% revenue growth and a proposed CMS LCD position the company for expanded US market access.AOTI
Q2 2026 TU - Revenue up 14% to $66.5M; CMS coverage could expand market 65-fold.AOTI
H2 2025 - FY 2025 revenue rose 14% to $66.5M, with growth despite Arizona Medicaid headwinds.AOTI
H2 2025 TU - Revenue up 26.5% in H1 2024; full-year growth above 30% expected after strong Q2.AOTI
H1 2024 TU - 26.4% revenue growth, margin gains, and IPO proceeds drive expansion and debt reduction.AOTI
H1 2024 - Revenue up 32.9% to $58.4M, with strong Medicaid growth and improved profitability.AOTI
H2 2024 - Revenue up 32% to $58.1m, margins and growth outlook strong with new market expansion.AOTI
H2 2024 TU - H1 2025 revenue up 18%, outlook trimmed amid US healthcare disruption; Medicaid access expands.AOTI
H1 2025 TU - H1 2025 revenue up 20.9% to $31.8m, with Medicaid and VA growth and key global validation milestones.AOTI
H1 2025